408 related articles for article (PubMed ID: 1562695)
1. Opportunistic mycoses in the immunocompromised host: experience at a cancer center and review.
Anaissie E
Clin Infect Dis; 1992 Mar; 14 Suppl 1():S43-53. PubMed ID: 1562695
[TBL] [Abstract][Full Text] [Related]
2. Systemic fungal infections: major problems in cancer patients.
Powles RL; Mehta J
Indian J Cancer; 1994 Sep; 31(3):180-4. PubMed ID: 8557296
[TBL] [Abstract][Full Text] [Related]
3. Fungal infections associated with malignancies, treatments, and AIDS.
Benedict S; Colagreco J
Cancer Nurs; 1994 Oct; 17(5):411-7. PubMed ID: 7954389
[TBL] [Abstract][Full Text] [Related]
4. Fungal infections in cancer patients: an escalating problem.
Samonis G; Bafaloukos D
In Vivo; 1992; 6(2):183-93. PubMed ID: 1525339
[TBL] [Abstract][Full Text] [Related]
5. Itraconazole: managing mycotic complications in immunocompromised patients.
Graybill JR
Semin Oncol; 1998 Jun; 25(3 Suppl 7):58-63. PubMed ID: 9671333
[TBL] [Abstract][Full Text] [Related]
6. Fungal infections in nontransplant patients with hematologic malignancies.
Segal BH; Bow EJ; Menichetti F
Infect Dis Clin North Am; 2002 Dec; 16(4):935-64, vii. PubMed ID: 12512188
[TBL] [Abstract][Full Text] [Related]
7. Recent progress and current problems in treatment of invasive fungal infections in neutropenic patients.
Walsh TJ; Hiemenz JW; Anaissie E
Infect Dis Clin North Am; 1996 Jun; 10(2):365-400. PubMed ID: 8803625
[TBL] [Abstract][Full Text] [Related]
8. Treatment of fungal and other opportunistic infections in immunocompromised patients.
Wade JC
Leukemia; 1997 May; 11 Suppl 4():S38-9. PubMed ID: 9179282
[TBL] [Abstract][Full Text] [Related]
9. Summaries for patients. Itraconazole and amphotericin B to treat fungal infections in patients with cancer who are receiving chemotherapy.
Ann Intern Med; 2001 Sep; 135(6):S-39. PubMed ID: 11575279
[No Abstract] [Full Text] [Related]
10. Current approaches to the management of fungal infections in cancer patients: Part 1.
Francis P; Walsh TJ
Oncology (Williston Park); 1992 Apr; 6(4):81-92; discussion 97-100. PubMed ID: 1533782
[TBL] [Abstract][Full Text] [Related]
11. Treatment of fungal infections in patients infected with the human immunodeficiency virus.
Sugar AM
Pharmacotherapy; 1990; 10(6 ( Pt 3)):154S-158S. PubMed ID: 2075115
[TBL] [Abstract][Full Text] [Related]
12. Disseminated Ochroconis gallopavum infection in a chronic lymphocytic leukemia: a case report and review of the literature on hematological malignancies.
Fukushima N; Mannen K; Okamoto S; Shinogi T; Nishimoto K; Sueoka E
Intern Med; 2005 Aug; 44(8):879-82. PubMed ID: 16157992
[TBL] [Abstract][Full Text] [Related]
13. Managing fungal and viral infection in the immunocompromised host.
Jehn U
Recent Results Cancer Res; 1988; 108():61-70. PubMed ID: 3051213
[TBL] [Abstract][Full Text] [Related]
14. [Controversial points in the treatment of patients with haematologic malignancies complicated with systemic fungal infections].
Mori T
Nihon Ishinkin Gakkai Zasshi; 1999; 40(3):143-9. PubMed ID: 10423582
[TBL] [Abstract][Full Text] [Related]
15. Recent progress and current problems in management of invasive fungal infections in patients with neoplastic diseases.
Walsh TJ; Lee JW; Roilides E; Pizzo PA
Curr Opin Oncol; 1992 Aug; 4(4):647-55. PubMed ID: 1511021
[TBL] [Abstract][Full Text] [Related]
16. Posaconazole: an extended-spectrum triazole antifungal agent.
Schiller DS; Fung HB
Clin Ther; 2007 Sep; 29(9):1862-86. PubMed ID: 18035188
[TBL] [Abstract][Full Text] [Related]
17. Recommendations for the treatment of established fungal infections.
Thursky KA; Playford EG; Seymour JF; Sorrell TC; Ellis DH; Guy SD; Gilroy N; Chu J; Shaw DR
Intern Med J; 2008 Jun; 38(6b):496-520. PubMed ID: 18588522
[TBL] [Abstract][Full Text] [Related]
18. Lethal disseminated Fusarium infection with sinus involvement in the immunocompromised host: case report and review of the literature.
Rombaux P; Eloy P; Bertrand B; Delos M; Doyen C
Rhinology; 1996 Dec; 34(4):237-41. PubMed ID: 9050104
[TBL] [Abstract][Full Text] [Related]
19. Current drug therapy of systemic mycoses: a review.
Yonga G
East Afr Med J; 1995 Jun; 72(6):394-8. PubMed ID: 7498014
[TBL] [Abstract][Full Text] [Related]
20. Trends in the epidemiology of opportunistic fungal infections: predisposing factors and the impact of antimicrobial use practices.
Singh N
Clin Infect Dis; 2001 Nov; 33(10):1692-6. PubMed ID: 11641825
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
